Although this enzyme has previously been linked to carcinogenesis in cultured cell models of colorectal and breast cancer (for example 69, 70), this is the first time that GALNT7 was shown to be increased at both a transcript and protein level in primary patient MLL-r cells compared to normal controls. Here, KMT2A is linked to breast carcinoma.